SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Newlink Genetics Corporation
(NASDAQ : NLNK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading NLNK News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.13%79.151.2%$812.67m
SRPTSarepta Therapeutics, Inc.
7.40%63.4830.9%$463.91m
AMGNAmgen Inc.
-0.45%170.851.1%$458.84m
BIIBBiogen Inc.
-0.01%314.511.0%$433.24m
MDVNMedivation, Inc.
0.05%81.481.9%$415.69m
CELGCelgene Corporation
-0.82%106.520.8%$379.97m
REGNRegeneron Pharmaceuticals, Inc.
-0.25%420.403.2%$312.06m
CPHDCepheid
-0.10%52.584.7%$210.84m
ALXNAlexion Pharmaceuticals, Inc.
-1.32%124.322.3%$171.74m
CLVSClovis Oncology, Inc.
-0.96%37.0825.5%$162.77m
ILMNIllumina, Inc.
-0.56%179.343.4%$138.01m
VRTXVertex Pharmaceuticals Incorporated
-1.25%88.012.2%$122.33m
INCYIncyte Corporation
5.92%94.352.7%$112.78m
BMRNBioMarin Pharmaceutical Inc.
-0.85%96.233.8%$112.50m
TSROTESARO, Inc.
-0.25%107.7715.9%$111.53m

Company Profile

NewLink Genetics Corp. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.